I don’t have one because I’m not looking for a short-term trade. I’m expecting IDIX to be a core biotech holding for a number of years, much as NVS was my core Big Pharma holding for many years until it finally became a Wall Street favorite and the valuation appreciated accordingly. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.